获得性重型再生障碍性贫血治疗方案的优化选择——没有配型相合同胞供者的年轻患者应该接受替代供者的移植

许兰平. 获得性重型再生障碍性贫血治疗方案的优化选择——没有配型相合同胞供者的年轻患者应该接受替代供者的移植[J]. 临床血液学杂志, 2016, 29(11): 871-873,876. doi: 10.13201/j.issn.1004-2806.2016.11.004
引用本文: 许兰平. 获得性重型再生障碍性贫血治疗方案的优化选择——没有配型相合同胞供者的年轻患者应该接受替代供者的移植[J]. 临床血液学杂志, 2016, 29(11): 871-873,876. doi: 10.13201/j.issn.1004-2806.2016.11.004
XU Lanping. Optimized choice of treatment regimen for acquired aplastic anemia——stem-cell transplantation from an alternative donor should be used in patients who lack an identical sibling donor[J]. J Clin Hematol, 2016, 29(11): 871-873,876. doi: 10.13201/j.issn.1004-2806.2016.11.004
Citation: XU Lanping. Optimized choice of treatment regimen for acquired aplastic anemia——stem-cell transplantation from an alternative donor should be used in patients who lack an identical sibling donor[J]. J Clin Hematol, 2016, 29(11): 871-873,876. doi: 10.13201/j.issn.1004-2806.2016.11.004

获得性重型再生障碍性贫血治疗方案的优化选择——没有配型相合同胞供者的年轻患者应该接受替代供者的移植

详细信息
    通讯作者: 许兰平,E-mail:lpxu_0415@sina.com
  • 中图分类号: R556.5

Optimized choice of treatment regimen for acquired aplastic anemia——stem-cell transplantation from an alternative donor should be used in patients who lack an identical sibling donor

More Information
  • 加载中
  • [1]

    Marsh JC,Ball SE,Cavenaqh J,et al.Guidelines for the diagnosis and management of aplastic anaemia[J].Br J Haematol,2009,147:43-70.

    [2]

    Killick SB,Bown N,Cavenagh J,et al.Guidelines for the diagnosis and management of adult aplastic anaemia[J].Br J Haematol,2016,172:187-207.

    [3]

    Barone A,Lucarelli A,Onofrillo D,et al.Diagnosis and management of acquired aplastic anemia in childhood.Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)[J].Blood Cells Mol Dis,2015,55:40-47.

    [4]

    Kosaka Y,Yagasaki H,Sano K,et al.Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia[J].Blood,2008,111:1054-1059.

    [5]

    Samarasinghe S,Steward C,Hiwarkar P,et al.Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy:a United Kingdom multicentre retrospective experience[J].Br J Haematol,2012,157:339-346.

    [6]

    Dufour C,Veys P,Carraro E,et al.Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia.A study on behalf of the UK Paediatric BMT Working Party,Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT[J].Br J Haematol,2015,171:585-594.

    [7]

    Devillier R,Dalle JH,Kulasekararaj A,et al.Unrelated alternative donor transplantation for severe acquired aplastic anemia:a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party[J].Haematologica,2016,101:884-890.

    [8]

    Chen J,Lee V,Luo CJ,et al.Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia:a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group[J].Br J Haematol,2013,162:383-391.

    [9]

    Im HJ,Koh KN,Choi ES,et al.Excellent outcome of haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia[J].Biol Blood Marrow Transplant,2013,19:754-759.

    [10]

    Xu LP,Liu KY,Liu DH,et al.A novel protocol for haploidentical hematopoietic SCT without in vitro T-[CM(71mm]cell depletion in the treatment of severe acquired aplastic anemia[J].Bone Marrow Transplant,2012,47:1507-1512.

    [11]

    Wang Z,Zheng X,Yan H,et al.Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia[J].Bone Marrow Transplantat,2014,49:1481-1485.

    [12]

    Gao L,Li Y,Zhang Y,et al.Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy[J].Bone Marrow Transplant,2014,49:519-524.

    [13]

    卢静,吴德沛,胡绍燕.不同方式异基因造血干细胞移植治疗63例重型再生障碍性贫血患者的预后比较[J].中华血液学杂志,2015,36(8):633-636.

    [14]

    Xu LP,Wang SQ,Wu DP,et al.Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study[J].Br J Haematol,2016 Jun 28.doi:10.1111/bjh.14225.[Epub ahead of print].

    [15]

    Xu LP,Zhang XH,Wang FR,et al.Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia[J].BMT (accepted).

    [16]

    Xu LP,Jin S,Wang CQ,et al.Upfront haploidentical transplant for acquired severe aplastic anemia:registry-based comparison with matched related transplant[J].BHO (accepted).

    [17]

    中华医学会血液学分会干细胞应用学组,中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅰ)——适应证、预处理方案及供者选择(2014年版)[J].中华血液学杂志,2014,35(8):775-780.

  • 加载中
计量
  • 文章访问数:  226
  • PDF下载数:  183
  • 施引文献:  0
出版历程
收稿日期:  2016-09-06

目录